The Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Myocardial Infarction and Mortality
Overview
Authors
Affiliations
Objective: The aim of the study was to examine the effects of the vitamin D (Vit-D) treatment and nontreatment on Vit-D-deficient patients without a prior history of myocardial infarction (MI).
Materials And Methods: This was a retrospective, observational, nested case-control study of patients (N = 20 025) with low 25-hydroxyvitamin D ([25-OH]D) levels (<20 ng/mL) who received care at the Veterans Health Administration from 1999 to 2018. Patients were divided into 3 groups: Group A (untreated, levels ≤20 ng/mL), Group B (treated, levels 21-29 ng/mL), and Group C (treated, levels ≥30 ng/mL). The risk of MI and all-cause mortality were compared utilizing propensity score-weighted Cox proportional hazard models.
Results: Among the cohort of 20 025 patients, the risk of MI was significantly lower in Group C than in Group B (hazard ratio [HR] 0.65, 95% CI 0.49-0.85, = .002) and Group A (HR 0.73, 95% CI 0.55-0.96), = .02). There was no difference in the risk of MI between Group B and Group A (HR 1.14, 95% CI 0.91-1.42, = 0.24). Compared with Group A, both Group B (HR 0.59, 95% CI 0.54-0.63, < .001) and Group C (HR 0.61, 95% CI 0.56-0.67, < .001) had significantly lower all-cause mortality. There was no difference in all-cause mortality between Group B and Group C (HR 0.99, 95% CI 0.89-1.09, = .78).
Conclusions: In patients with Vit-D deficiency and no prior history of MI, treatment to the (25-OH)D level of >20 ng/mL and >30 ng/mL was associated with a significantly lower risk of all-cause mortality. The lower risk of MI was observed only in individuals maintaining (25-OH)D levels ≥30 ng/mL.
Balasubramanian A, Kunchala K, Shahbaz A, Kar A, Sankar J, Anand S Cureus. 2025; 17(1):e77375.
PMID: 39944452 PMC: 11817865. DOI: 10.7759/cureus.77375.
Illuminating the Connection: Cutaneous Vitamin D Synthesis and Its Role in Skin Cancer Prevention.
Ucar N, Holick M Nutrients. 2025; 17(3).
PMID: 39940244 PMC: 11821240. DOI: 10.3390/nu17030386.
Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines.
Grant W, Wimalawansa S, Pludowski P, Cheng R Nutrients. 2025; 17(2).
PMID: 39861407 PMC: 11767646. DOI: 10.3390/nu17020277.
Ojaroodi A, Jafarnezhad F, Eskandari Z, Keramat S, Stanek A Nutrients. 2025; 17(1.
PMID: 39796525 PMC: 11722561. DOI: 10.3390/nu17010090.
Aleksova A, Janjusevic M, Pani B, Hiche C, Chicco A, Derin A J Clin Med. 2024; 13(22).
PMID: 39597936 PMC: 11594877. DOI: 10.3390/jcm13226792.